Activated keratinocytes release cytokines and chemokines, and thymus- and activation-regulated chemokines (TARC/CCL17) and macrophage-derived chemokines (MDC/CCL22) are highly increased at the serum level in individuals with AD [7,8,9,10,11]. This evidence concerns the gene CCL17 and Alzheimer disease.